The Results of Treatment in Children With AML and Initial Hyperleucocytosis According to the AML-MM-2006 Protocol

Pediatric Hematology/Oncology and Immunopathology - Russian Federation
doi 10.24287/1726-1708-2020-19-1-9-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Fund Doctors, Innovations, Science for Children

Related search

Modern Strategies in AML Treatment

Russian Journal of Children Hematology and Oncology
2016English

What Happens Subsequently in AML When Cytogenetic Abnormalities Persist at Bone Marrow Harvest? Results of the 10th UK MRC AML Trial

Bone Marrow Transplantation
TransplantationHematology
1997English

Use of Granulocyte Colony-Stimulating Factor and Risk of Relapse in Pediatric Patients Treated for Acute Myeloid Leukemia According to NOPHO-AML 2004 and DB AML-01

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2019English

CEBPA-dependent HK3 and KLF5 Expression in Primary AML and During AML Differentiation

Scientific Reports
Multidisciplinary
2014English

Personalized Medicine Applied to AML

Cancer Discovery
Oncology
2018English

Targeting mTOR for the Treatment of AML. New Agents and New Directions.

Oncotarget
Oncology
2011English

Long-Term Outcome of Cord Blood Transplantation From Unrelated Donors as an Initial Transplantation Procedure for Children With AML in Japan

Bone Marrow Transplantation
TransplantationHematology
2009English

Molecular Genetics of AML

Best Practice and Research in Clinical Haematology
OncologyClinical Biochemistry
2012English

Donor HSCs With a Preexisting ASXL1-mutation Led to the Development of FLT3-ITD Positive AML in the Donor and FLT3-ITD Negative AML in the Recipient After Unrelated Transplant

Bone Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy